九源基因发布上市后首份业绩公告!2024年实现营收13.69亿元 骨科产品复合增长率超33%

智通财经网
27 Mar

智通财经APP获悉,3月26日,九源基因(02566)公布了上市后首份年度业绩公告,公司2024年实现总收入13.69亿元,同比增长6.4%;净利润1.386亿元,同比增长15.7%。实现净利率10.12%,比上年同期增长0.82%;实现毛利率79%,比上年同期增长2.05%,展示出强劲的业务增长势头和盈利能力。在营收稳健向好的同时,2024年,九源基因持续加大研发投入,在骨科、代谢、肿瘤与血液...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10